URGN
UroGen Pharma Ltd.
Company Overview
| Mkt Cap | $933.61M | Price | $20.47 |
| Volume | 813.55K | Change | +3.12% |
| P/E Ratio | -7.4 | Open | $19.99 |
| Revenue | $90.4M | Prev Close | $19.85 |
| Net Income | $-126.9M | 52W Range | $3.42 - $21.71 |
| Div Yield | N/A | Target | $33.75 |
| Overall | 51 | Value | 40 |
| Quality | 50 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyUroGen Pharma Ltd. (URGN) is a leading Healthcare company in the Biotechnology industry, currently trading at $20.47 with a market capitalization of $933.61 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows URGN with a volume of 814K shares. The stock opened up 0.71% from yesterday's close of $19.85. Current analyst estimates project earnings of $-3.18 per share for this year, with next year targeting $-1.17.
URGN demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for URGN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 64.9%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 01:19 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $20.47 | +3.1% | 813.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |